181 related articles for article (PubMed ID: 23533167)
1. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.
Hsu SH; Motiwala T; Roy S; Claus R; Mustafa M; Plass C; Freitas MA; Ghoshal K; Jacob ST
J Cell Biochem; 2013 Aug; 114(8):1810-8. PubMed ID: 23533167
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.
Hou J; Xu J; Jiang R; Wang Y; Chen C; Deng L; Huang X; Wang X; Sun B
Hepatology; 2013 Feb; 57(2):678-88. PubMed ID: 22821478
[TBL] [Abstract][Full Text] [Related]
3. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas.
Motiwala T; Ghoshal K; Das A; Majumder S; Weichenhan D; Wu YZ; Holman K; James SJ; Jacob ST; Plass C
Oncogene; 2003 Sep; 22(41):6319-31. PubMed ID: 14508512
[TBL] [Abstract][Full Text] [Related]
5. VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma.
Liu Y; Hei Y; Shu Q; Dong J; Gao Y; Fu H; Zheng X; Yang G
PLoS One; 2012; 7(4):e35800. PubMed ID: 22536440
[TBL] [Abstract][Full Text] [Related]
6. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
[TBL] [Abstract][Full Text] [Related]
7. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.
Xu D; Wang X; Yan S; Yin Y; Hou J; Wang X; Sun B
Tumour Biol; 2014 Oct; 35(10):10267-73. PubMed ID: 25034527
[TBL] [Abstract][Full Text] [Related]
8. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
Ming F; Sun Q
Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
10. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.
Ramaswamy B; Majumder S; Roy S; Ghoshal K; Kutay H; Datta J; Younes M; Shapiro CL; Motiwala T; Jacob ST
Mol Endocrinol; 2009 Feb; 23(2):176-87. PubMed ID: 19095770
[TBL] [Abstract][Full Text] [Related]
12. PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy.
Huang YT; Li FF; Ke C; Li Z; Li ZT; Zou XF; Zheng XX; Chen YP; Zhang H
J Transl Med; 2013 Oct; 11():245. PubMed ID: 24090193
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.
Yamamoto S; Tomita Y; Nakamori S; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M; Aozasa K
J Clin Oncol; 2003 Feb; 21(3):447-52. PubMed ID: 12560433
[TBL] [Abstract][Full Text] [Related]
14. Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1.
Zhang SH; Liu J; Kobayashi R; Tonks NK
J Biol Chem; 1999 Jun; 274(25):17806-12. PubMed ID: 10364224
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
16. Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.
Li SY; Li R; Chen YL; Xiong LK; Wang HL; Rong L; Luo RC
BMC Genet; 2014 Jun; 15():67. PubMed ID: 24919593
[TBL] [Abstract][Full Text] [Related]
17. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY
Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Suppression Mechanisms of Protein Tyrosine Phosphatase O and Clinical Applications.
Kang MM; Shan SL; Wen XY; Shan HS; Wang ZJ
Asian Pac J Cancer Prev; 2015; 16(15):6215-23. PubMed ID: 26434819
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
20. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
